Dentsply Int'l (XRAY) Reports In-Line Q2 EPS, Sales Miss; Guides EPS Below the Street

Dentsply Int'l (NASDAQ: XRAY) reported Q2 EPS of $0.65, in-line with the analyst estimate of $0.65. Revenue for the quarter came in at $992.7 million versus the consensus estimate of $1 billion.

GUIDANCE:

Dentsply Int'l sees FY2017 EPS of $2.65-$2.75, versus the consensus of $2.84.

For earnings history and earnings-related data on Dentsply Int'l (XRAY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c